Mergers & Acquisitions

  • October 27, 2025

    Holland & Knight's CFIUS Team Leader Jumps To Weil

    The leader of Holland & Knight LLP's Committee on Foreign Investment in the United States and industrial security team has made the move to Weil Gotshal & Manges LLP in Washington, D.C., the firm announced Monday.

  • October 27, 2025

    Trian, General Catalyst Make $7.2B Play For Janus Henderson

    Janus Henderson Group said Monday it has received a $7.2 billion buyout offer from Trian Fund Management LP and General Catalyst Group Management LLC, which say the British asset management firm could more effectively achieve its goals as a private company.

  • October 27, 2025

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court and Delaware Supreme Court saw another busy week of disputes spanning biotech milestones, reincorporation showdowns, shareholder voting schemes and cryptocurrency fiduciary rights.

  • October 27, 2025

    Compass Pushes For Redfin Docs In Zillow Antitrust Fight

    Compass Inc. has urged a New York federal court presiding over the brokerage's antitrust suit against property listings company Zillow Inc. to order another property listings company, Redfin Corp., to provide copies of drafts of blog posts written by Redfin's CEO as well as a copy of an allegedly anticompetitive Zillow-Redfin rental agreement.

  • October 27, 2025

    Top FTC Atty In Meta And Amazon Cases Joins WilmerHale

    A former chief trial counsel at the Federal Trade Commission's Bureau of Competition, who was one of the lead attorneys on the agency's landmark monopolization cases against Amazon and Meta, has joined WilmerHale's Washington, D.C. office, the firm announced Monday.

  • October 27, 2025

    Paul Weiss, K&L Gates Lead $660M Albemarle, Ketjen Deals

    K&L Gates LLP-advised Albemarle Corp. on Monday announced that it has agreed to sell a majority stake in Ketjen Corp.'s refining catalyst solutions business to Paul Weiss Rifkind Wharton & Garrison LLP-led private equity shop KPS Capital Partners, and separately announced it will sell a 50% interest in a joint venture with Ketjen to Axens SA in two deals that will provide the company with pre-tax proceeds of around $660 million.

  • October 27, 2025

    Schroders Portfolio Biz Agrees Sale To Data Co. For $1.7B

    Schroders Capital Global Innovation Trust PLC said Monday that its portfolio company, Securiti AI, has signed an agreement to be acquired by private equity-backed business Veeam Software for approximately $1.7 billion.

  • October 27, 2025

    Wachtell-Led Huntington Strikes $7.4B Deal For Cadence Bank

    Huntington Bancshares Inc. said Monday it has agreed to acquire Cadence Bank for $7.4 billion in one of the top banking sector deals of 2025, with Wachtell Lipton advising Huntington and Sullivan & Cromwell guiding Cadence. 

  • October 27, 2025

    UK Raises Antitrust Concern Over £1.2B Greencore Deal

    The Competition and Markets Authority said on Monday that Greencore's planned £1.2 billion ($1.6 billion) deal for meals producer Bakkavor might harm competition in the U.K.'s market for chilled sauces.

  • October 27, 2025

    Covington Helps Novartis Buy Avidity Biosciences For $12B

    Swiss pharmaceutical giant Novartis AG has said it will buy Avidity Biosciences, a U.S. developer of therapeutics for muscle diseases, for approximately $12 billion in a move to boost its neuroscience portfolio.

  • October 26, 2025

    7 Firms Steer $2.1B Take-Private Deal For Plymouth REIT

    Real estate investment firm Makarora Management LP and Ares Management Corp. have agreed to acquire and take private Plymouth Industrial REIT Inc. in a $2.1 billion cash deal guided by seven law firms, coming three months after a competing buyout offer for Plymouth.

  • October 24, 2025

    JPMorgan Accuses Charlie Javice Of 'Abusive' Atty Fee Billing

    JPMorgan Chase & Co. on Friday asked a Delaware state judge to reverse a 2023 order requiring the bank to cover the legal fees of convicted Frank founder Charlie Javice, arguing that the court must put a stop to her "abusive billing."

  • October 24, 2025

    X Corp. Says Ex-Twitter Workers' Bid Is Too Little, Too Late

    Elon Musk's X Corp. told a Delaware federal judge that six former Twitter workers' bid to revive their dismissed severance claims by raising fresh contract theories and stale arbitration testimony is "far too little, far too late."

  • October 24, 2025

    Avalara Investors Fight Stay In $8.4B Buyout Dispute

    Shareholders of tax software company Avalara are fighting a motion by the company in Washington federal court to stay litigation accusing it of misleading investors ahead of an $8.4 billion deal to take the company private.

  • October 24, 2025

    Off The Bench: NBA Gambling Woes, Golfer's $50M Trial Win

    In this week's Off The Bench, the NBA faces a gambling scandal during its opening week, a Florida jury hands golfer Jack Nicklaus a $50 million victory in his defamation lawsuit, and DraftKings and the NHL step into the realm of prediction markets.

  • October 24, 2025

    Sterlington Founder Talks C-Suite Guidance After $40B Deal

    On the heels of representing Aligned Data Centers' management in the company's $40 billion sale, Sterlington PLLC founder Chris Harrison spoke with Law360 about fundamental changes reshaping negotiations with buyers as private equity strategies evolve.

  • October 24, 2025

    Paris-Based SPAC Targets US Acquisition After Raising $100M

    French special purpose acquisition company LaFayette Acquisition Corp. began trading publicly on Friday after raising $100 million in its U.S. initial public offering, with plans to target U.S. companies in a range of industries.

  • October 24, 2025

    RunItOneTime Tells Judge Debtor In Talks For More DIP Cash

    RunItOneTime LLC told a Texas bankruptcy judge on Friday it is in talks with its post-petition financing lender for more funds as it prepares to face the loss of operating cash from assets subject to sales the debtor hopes to close.

  • October 24, 2025

    Eli Lilly Buying Eye Disease Biotech For Up To $262M

    Ropes & Gray LLP-advised Eli Lilly said Friday it has agreed to acquire Cooley LLP-guided Adverum Biotechnologies, a clinical-stage company developing gene therapies for eye diseases, for up to roughly $262 million. 

  • October 24, 2025

    Taxation With Representation: Latham, Wachtell, Gibson Dunn

    In this week's Taxation With Representation, Meta announces a joint venture with Blue Owl Capital to fund the development of a data center campus in Louisiana, private equity giants acquire medical technology company Hologic Inc., and National Fuel Gas Co. buys CenterPoint Energy Inc.'s Ohio natural gas utility business.

  • October 24, 2025

    CMA Concerned Over Aramark Deal For Scottish Catering Co.

    Britain's antitrust enforcer has clarified its concerns with Aramark Group's completed acquisition of Scottish catering company Entier Ltd. over the supply of catering and related services for the offshore energy sector.

  • October 24, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen the Financial Conduct Authority launch legal action against a Chinese cryptocurrency exchange, The Londoner magazine face a defamation claim from an entrepreneur accused of "scamming" Knightsbridge landlords, and Gucci sued by its cosmetics supplier as L'Oréal announces plans to buy the Italian fashion house's beauty brand. Here, Law360 looks at these and other new claims in the U.K.

  • October 24, 2025

    Warburg Pincus, Permira Get More Time To Bid For JTC

    Professional services provider JTC said Friday that the takeover panel has given two separate private equity firms an extension to table formal offers to acquire the professional services or walk away.

  • October 23, 2025

    Chancery Maps Out Math For Hefty Drug Co. Breach Interest

    A Delaware vice chancellor late Thursday issued a road map for calculating tens of millions of dollars in interest due after a ruling in June that Alexion Pharmaceuticals failed a "best efforts" duty to fulfill an autoimmune drug candidate deal with Syntimmune Inc.

  • October 23, 2025

    Japan's Jera Paying $1.5B For Louisiana Shale Gas Assets

    Japanese power company Jera Co. said Thursday it has agreed to acquire shale gas assets in Louisiana from Williams Cos. and GEP Haynesville II LLC for about $1.5 billion, with Baker Botts LLP steering Jera on the deal. 

Expert Analysis

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Identifying Data Center Investment Challenges, Opportunities

    Author Photo

    The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.